Taking people in Finnország2. fázis
Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer
Key facts
- Where
- Turku, FinnországSee the site
- Phase
- 2. fázis
Where in Finnország
- Turku University HospitalTurku, FinnországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Turku University Hospital
- Trial code
- EU 2023-510208-39-00
- Record updated
- 2024. augusztus 20.
- Original description
To assess the accuracy of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patient level in patients with primary pancreatic cancer.Read full original descriptionShow less
To assess the accuracy of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patient level in patients with primary pancreatic cancer.
Inclusion: Primary or recurrent pancreatic cancer; Suspected primary or recurrent pancreatic cancer; Male or female aged 18-85 years; WHO performance score 0-2; Study subject signs informed consent form after receiving written information.
Exclusion: Medical conditions prohibiting whole-body PET/CT imaging; Vulnerable study subjects such as described in Finnish law clinical studies (disabled, children, pregnant or breast-feeding women, prisoners) will not be included; Study subject is not able to understand the purpose of the study.